| Nov 19 |
Q3 2024 Cellectar Biosciences Inc Earnings Call
|
| Nov 18 |
Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript
|
| Nov 18 |
Cellectar Biosciences GAAP EPS of -$0.40 misses by $0.03
|
| Nov 18 |
Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
|
| Nov 18 |
Earnings Scheduled For November 18, 2024
|
| Nov 15 |
Cellectar Biosciences Q3 2024 Earnings Preview
|
| Nov 14 |
Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225
|
| Nov 12 |
Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer
|
| Nov 11 |
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024
|
| Nov 7 |
Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024
|
